ODTX
Odyssey Therapeutics, Inc.
20.70$
+1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | |
| 1,793.7% | 2,021.6% | 3,151.9% | – | – | |
| 421.5% | 414.6% | 1,378.4% | – | – | |
| 2,215.2% | 2,436.2% | 4,530.3% | – | – | |
| -2,115.2% | -2,336.2% | -4,430.3% | – | – | |
| 0.2% | 0.1% | 0.2% | – | – | |
| -2,044.7% | -1,996.6% | -4,296.7% | – | – | |
| -2,047.4% | -2,003.9% | -4,299.8% | – | – | |
| -1,970.8% | -1,928.8% | -4,164.3% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.